Circulating soluble receptor for advanced glycation end products and other factors in type 2 diabetes patients with colorectal cancer

BACKGROUND: Recent study showed that individuals with type 2 diabetes have a high risk of developing colorectal cancer (CRC), in which Receptor for Advanced Glycation End Products (RAGE) plays a pivotal role. We conducted a cross-sectional study to examine the relationships of circulating sRAGE, CRC...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Xiaohai, Lin, Ning, Zhang, Mingjie, Wang, Xiaoling, An, Ye, Su, Qing, Du, Peng, Li, Bo, Chen, Hanbei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7666469/
https://www.ncbi.nlm.nih.gov/pubmed/33187505
http://dx.doi.org/10.1186/s12902-020-00647-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7666469/
https://www.ncbi.nlm.nih.gov/pubmed/33187505
http://dx.doi.org/10.1186/s12902-020-00647-9

Ejemplares similares